Antitussive activity of the tachykinin NK1 receptor antagonist, CP-99994, in dogs

被引:18
|
作者
Chapman, RW [1 ]
House, A [1 ]
Liu, F [1 ]
Celly, C [1 ]
Mei, H [1 ]
Hey, JA [1 ]
机构
[1] Schering Plough Res Inst, Kenilworth, NJ 07033 USA
关键词
cough; tachykinin NK1 receptor; CP-99994; (dog);
D O I
10.1016/j.ejphar.2003.11.048
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CP-99994 [(+)-(2S,3S)-3-(2-methoxybenzylamino)-2-phenylpiperidine] is a selective tachykinin NK1 receptor antagonist that inhibits cough in guinea pigs and cats. This study examined the antitussive effects of CP-99994 in dogs produced by mechanical stimulation of the intrathoracic trachea. CP-99994 (10 mg/kg, p.o.) inhibited cough frequency by 52% at 2 h, 31% at 6 h and by 21% at 24 h. Cough amplitude was inhibited by 45% at 6 h but unchanged at 2 and 24 h after CP-99994. Plasma levels of CP-99994 were highest at 2 h (75 +/- 26 ng/ml) and fell to 22 +/- 6 ng/ml at 6 h. These results demonstrate antitussive activity of CP-99994 in dogs at a dose proven to antagonize tachykinin NK1 receptors in this species. (C) 2003 Elsevier B.V All rights reserved.
引用
收藏
页码:329 / 332
页数:4
相关论文
共 50 条
  • [41] EFFECTS OF RACEMIC CP-99,994, A TACHYKININ NK1 RECEPTOR ANTAGONIST, ON MOTION-INDUCED EMESIS IN SUNCUS-MURINUS
    GARDNER, CJ
    TWISSELL, DJ
    GALE, JD
    KILPATRICK, GJ
    WARD, P
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 : P250 - P250
  • [42] The tachykinin NK1 receptor in the brain:: pharmacology and putative functions
    Saria, A
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 375 (1-3) : 51 - 60
  • [43] Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK1 receptor antagonist
    Ballard, TM
    Sänger, S
    Higgins, GA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 412 (03) : 255 - 264
  • [44] Evaluation of PD154075, a tachykinin NK1 receptor antagonist, in a rat model of postoperative pain
    Gonzalez, M
    Field, MJ
    Holloman, EF
    Hughes, J
    Oles, RJ
    Singh, L
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 344 (2-3) : 115 - 120
  • [45] Stress-induced increase of cortical dopamine metabolism:: attenuation by a tachykinin NK1 receptor antagonist
    Hutson, PH
    Patel, S
    Jay, MT
    Barton, CL
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 484 (01) : 57 - 64
  • [46] Delayed NK1 tachykinin receptor antagonist treatment reduces ICP following stroke in an Ovine model
    Sorby-Adams, A.
    Leonard, A.
    Thornton, E.
    Hunter, D.
    Turner, R.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2017, 37 : 210 - 210
  • [47] NK1, NK2 and NK3 tachykinin receptor localization and tachykinin distribution in the ileum of the mouse
    Vannucchi, MG
    Faussone-Pellegrini, MS
    ANATOMY AND EMBRYOLOGY, 2000, 202 (03): : 247 - 255
  • [48] NK1, NK2 and NK3 tachykinin receptor localization and tachykinin distribution in the ileum of the mouse
    M. -G. Vannucchi
    M. -S. Faussone-Pellegrini
    Anatomy and Embryology, 2000, 202 : 247 - 255
  • [49] NK1 antagonist
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1997, 2 (04) : 162 - 162
  • [50] Aprepitant and L-758298 -: Antiemetic -: Antidepressant -: Tachykinin Nk1 antagonist
    Sorbera, LA
    Castañer, J
    Bayés, M
    Silvestre, J
    DRUGS OF THE FUTURE, 2002, 27 (03) : 211 - 222